A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

Benzer Materyaller

• Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
  Yazar:: McLaurin, Eugene B., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
  Yazar:: Ayyappanavar, Shruti, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
  Yazar:: Ciolino, Joseph B, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
  Yazar:: Greiner, Jack V, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• 364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies
  Yazar:: Blaiss, Michael S., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)